ZA202110111B - Methods and compositions for treating liver disorders - Google Patents

Methods and compositions for treating liver disorders

Info

Publication number
ZA202110111B
ZA202110111B ZA2021/10111A ZA202110111A ZA202110111B ZA 202110111 B ZA202110111 B ZA 202110111B ZA 2021/10111 A ZA2021/10111 A ZA 2021/10111A ZA 202110111 A ZA202110111 A ZA 202110111A ZA 202110111 B ZA202110111 B ZA 202110111B
Authority
ZA
South Africa
Prior art keywords
compositions
methods
liver disorders
disorders
treating liver
Prior art date
Application number
ZA2021/10111A
Other languages
English (en)
Inventor
Kolterman Orville
Perraudeau Fanny
Bullard James
Eid John
Cutcliffe Colleen
Original Assignee
Pendulum Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pendulum Therapeutics Inc filed Critical Pendulum Therapeutics Inc
Publication of ZA202110111B publication Critical patent/ZA202110111B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA2021/10111A 2019-05-21 2021-12-07 Methods and compositions for treating liver disorders ZA202110111B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962850773P 2019-05-21 2019-05-21
PCT/US2020/033870 WO2020236979A1 (en) 2019-05-21 2020-05-20 Methods and compositions for treating liver disorders

Publications (1)

Publication Number Publication Date
ZA202110111B true ZA202110111B (en) 2024-04-24

Family

ID=73458208

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2021/10111A ZA202110111B (en) 2019-05-21 2021-12-07 Methods and compositions for treating liver disorders

Country Status (10)

Country Link
US (1) US20220211780A1 (cg-RX-API-DMAC10.html)
EP (1) EP3973047A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022533672A (cg-RX-API-DMAC10.html)
KR (1) KR20220011683A (cg-RX-API-DMAC10.html)
CN (1) CN113993529A (cg-RX-API-DMAC10.html)
AU (1) AU2020278703A1 (cg-RX-API-DMAC10.html)
CA (1) CA3140096A1 (cg-RX-API-DMAC10.html)
SG (1) SG11202112515RA (cg-RX-API-DMAC10.html)
WO (1) WO2020236979A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202110111B (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
EP3973047A4 (en) * 2019-05-21 2023-01-11 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF LIVER DISEASES
NL2030011B1 (en) * 2021-12-03 2023-06-20 Caelus Pharmaceuticals B V Prevention or treatment of hepatic steatosis
EP4467148A4 (en) * 2022-01-20 2025-04-23 Korea Institute of Science and Technology Composition for prevention, amelioration or treatment of non-alcoholic fatty liver disease, comprising extracellular vesicles derived from roseburia spp. or bifidobacterium spp
CN117599092B (zh) * 2024-01-23 2024-04-26 南方医科大学南方医院 生孢梭菌在制备预防和/或治疗肝脏疾病的药物中的应用
CN118526527A (zh) * 2024-03-19 2024-08-23 华中科技大学同济医学院附属协和医院 益生菌混合液在制备预防或治疗apap诱导肝损伤药物中的应用
KR102679094B1 (ko) * 2024-04-24 2024-06-27 충남대학교 산학협력단 항비만 효능을 지닌 한국인 마이크로바이옴 유래 클로스트리디움 부티리쿰 균주 및 이의 용도
CN119639633A (zh) * 2025-02-18 2025-03-18 杭州师范大学附属医院(杭州市第二人民医院) 一种治疗非酒精性脂肪肝的酵母菌益生菌复合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4529950A3 (en) * 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
JP7311267B2 (ja) * 2016-01-11 2023-07-19 エゲティス・セラピューティクス・アーベー 急性肝不全及び他の肝毒性状態を治療及び／又はこれらから保護するための方法及び製剤
WO2018106844A1 (en) * 2016-12-06 2018-06-14 Whole Biome Inc. Methods and compositions relating to isolated and purified microbes
WO2019046646A1 (en) * 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN111527195B (zh) * 2017-09-28 2023-11-03 Ko生物技术有限公司 用产生短链脂肪酸的肠道细菌群落的改变诊断和治疗酒精性肝病的组合物
JP2022502373A (ja) * 2018-09-24 2022-01-11 ペンデュラム セラピューティクス， インコーポレイテッド 微生物組成物および使用方法
EP3973047A4 (en) * 2019-05-21 2023-01-11 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF LIVER DISEASES

Also Published As

Publication number Publication date
JP2022533672A (ja) 2022-07-25
US20220211780A1 (en) 2022-07-07
EP3973047A1 (en) 2022-03-30
EP3973047A4 (en) 2023-01-11
WO2020236979A1 (en) 2020-11-26
CN113993529A (zh) 2022-01-28
CA3140096A1 (en) 2020-11-26
AU2020278703A1 (en) 2022-01-27
KR20220011683A (ko) 2022-01-28
SG11202112515RA (en) 2021-12-30

Similar Documents

Publication Publication Date Title
PH12020551425A1 (en) Rimegepant for cgrp related disorders
PH12019500521A1 (en) Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
EP4140487A8 (en) Combination therapy for treating cancer
MX2017015938A (es) Inhibidores de ezh2 para el tratar linfomas.
MX2019009227A (es) Métodos para tratar cáncer con inhibidores de hsp90.
MX2016007351A (es) Terapia de combinacion para tratar cancer.
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
MX2020008680A (es) Terapia de combinacion con apilimod y agentes glutamatergicos.
SG10201907660YA (en) Use of short chain fatty acids in cancer prevention
AU2018264384A1 (en) Solid forms of berberine ursodeoxycholate and compositions and methods thereof
EA201200793A1 (ru) Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
EA201000016A1 (ru) Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями
WO2015095834A3 (en) Cancer treatments using erk1/2 and bcl-2 family inhibitors
EA201991951A1 (ru) Низковязкие высококонцентрированные составы на основе эволокумаба и способы их получения
BR112016027043A8 (pt) combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
BR112015010039A2 (pt) tratamento de câncer com pomalidomida em um individuo com disfunção renal
PH12020500666A1 (en) Pladienolide compounds and their use
MX2021009247A (es) Metodos, sistemas y kits para tratar enfermedades inflamatorias que se dirigen a il18r1.
MX2015009696A (es) Composiciones estables que comprenden heparinoide, anestesico de accion aguda y regulador de ph.
PH12019502086A1 (en) Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
MX2020007619A (es) Intervenciones dirigidas, encaminadas a reducir los niveles de succinato circulante en un sujeto, y kits y metodo para determinar la eficacia de dichas intervenciones.
PH12018501790A1 (en) Treatment of patients with homozygous familial hypercholesterolemia on lipid lowering therapy
BR112022007010A2 (pt) Terapia gênica para doença de alzheimer
WO2020039088A3 (en) Aromatic molecules for use in the treatment of pathological conditions
MX2017009963A (es) Composición y método para el tratamiento de padecimientos de la piel.